AirFluSal MDI 25 microgram / 125 microgram / dose pressurised inhalation, suspension

Licence status
Authorised: 12/05/2017
Active substances
SALMETEROL XINAFOATE, Fluticasone propionate
Dosage Form
Pressurised inhalation, suspension
Licence number
PA0711/270/001
Licence holder
Rowex Ltd

Product documents

Licence information

ATC code
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, R03AK06 salmeterol and fluticasone
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
12/05/2017

Interchangeable information